3 results
The primary objective is to obtain post-market clinical data according to the requirements of the MEDDEV 2.21/2 in order to fulfil 18 post-market surveillance (PMS) obligations according to Section 3.1 of Annex II, 19 Section 3 of Annex IV, Section…
Primary Objective: Validation of T1rho&T2mapping in healthy volunteers and patients with an OCD of the talusSecondary objective: To quantify T1rho & T2 mapping in patients with osteochondrial defects against healthy volunteers with…
Main objective: determine whether afamelanotide implants can reduce the severity of the skin disease in patients with VPSecondary objectives: Evaluate the safety and tolerability of afamelanotide in patients with VP. Evaluate the impact of…